Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Microbot Medical Inc. (MBOT : NSDQ)

• Company Description    Microbot Medical Inc. is engaged in the research, design, development and commercialization of micro-robotics assisted medical technologies. Its product candidate includes the Self Cleaning Shunt for the treatment of hydrocephalus and Normal Pressure Hydrocephalus and TipCAT, a self-propelling, semi-disposable endoscope which is being developed initially for use in colonoscopy procedures. Microbot Medical Inc., formerly known as Stemcells, Inc., is headquartered in Hingham, MA. Number of Employees: 3

• Price / Volume Information    Yesterday's Closing Price: $5.00 Daily Weekly Monthly 20 Day Moving Average: 18,815 shares Shares Outstanding: 7.11 (millions) Market Capitalization: $35.54 (millions) Beta: 3.98 52 Week High: $9.60 52 Week Low: $4.31 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -21.75% -14.58% 12 Week -13.79% -6.83% Year To Date -33.33% -21.03%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 25 RECREATION PARK DRIVE UNIT 108 - HINGHAM,MA 02043 USA ph: 781-875-3605 fax: 781-556-5347 mpolyviou@evcgroup.com http://www.microbotmedical.com

• General Corporate Information    Officers Harel Gadot - Chief Executive Officer; Chairman and President David Ben Naim - Chief Financial Officer Yoseph Bornstein - Director Prattipati Laxminarain - Director Scott Burell - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 59503A204 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/21 Next Expected EPS Date: 05/16/22 Share - Related Items Shares Outstanding: 7.11 Most Recent Split Date: 9.00 (0.07:1) Beta: 3.98 Market Capitalization: $35.54 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.42 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.62 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 05/16/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.47 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -2.86% vs. Previous Quarter: -2.86% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/22 - - 12/31/21 - -60.58 09/30/21 - -47.70 ROA 03/31/22 - - 12/31/21 - -54.85 09/30/21 - -43.87 Current Ratio 03/31/22 - - 12/31/21 - 8.00 09/30/21 - 13.47 Quick Ratio 03/31/22 - - 12/31/21 - 8.00 09/30/21 - 13.47 Operating Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Net Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Pre-Tax Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Book Value 03/31/22 - - 12/31/21 - 2.02 09/30/21 - 2.51 Inventory Turnover 03/31/22 - - 12/31/21 - - 09/30/21 - - Debt-to-Equity 03/31/22 - - 12/31/21 - 0.00 09/30/21 - 0.00 Debt-to-Capital 03/31/22 - - 12/31/21 - 0.00 09/30/21 - 0.00

Powered by Zacks Investment Research ©